Skip to main content
Top
Published in: Abdominal Radiology 4/2019

01-04-2019

Radiological patterns of secondary sclerosing cholangitis in patients after lung transplantation

Authors: Hye Jin Kim, Mi-Suk Park, Jin Woo Son, Kyunghwa Han, Jei Hee Lee, Jai Keun Kim, Hyo Chae Paik

Published in: Abdominal Radiology | Issue 4/2019

Login to get access

Abstract

Purpose

The purpose of this study was to investigate the radiological patterns of secondary sclerosing cholangitis (SSC) following lung transplantation.

Methods

Fifty-five patients underwent abdominopelvic CT before and after lung transplantation for end stage pulmonary disease. Nine patients underwent MR cholangiopancreatography (MRCP). The radiological patterns of biliary abnormalities (location, bile duct dilatation with stricture, beaded appearance, and biliary casts/sludge), laboratory data (serum total bilirubin and alkaline phosphatase), and patient survival rates were evaluated. SSC was diagnosed when there were newly developed biliary abnormalities with cholestasis after lung transplantation. Potential perioperative risk factors pertaining to SSC were analyzed. Patient survival rates with or without SSC were compared.

Results

Six of the 55 patients showed imaging and laboratory findings of SSC after lung transplantation. Multifocal dilatation and stricture involved the intrahepatic (6 of 6, 100%), hilar (4 of 6, 66.7%), and extrahepatic bile duct (1 of 6, 16.7%). On CT, the lesions presented as multifocal small cyst-like lesions along the bile duct course. On MRCP, the lesions showed beaded appearance with mild duct dilatation. Preoperative mechanical ventilation and bilateral lung transplantation were associated with SSC (p < 0.05). The median survival of patients with SSC was 4.6 months.

Conclusion

Lung transplantation can induce SSC similar to SSC in critically ill patients, and result in worse clinical outcomes than in patients without SSC. Multifocal small cyst-like lesions along the intrahepatic bile duct on CT and beaded appearance on MRCP are suggestive findings of SSC in patients with cholestasis after lung transplantation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooling J, Leal R (2017) Secondary sclerosing cholangitis: a review of recent literature. Curr Gastroenterol Rep 19:44CrossRefPubMed Brooling J, Leal R (2017) Secondary sclerosing cholangitis: a review of recent literature. Curr Gastroenterol Rep 19:44CrossRefPubMed
2.
go back to reference Seo N, Kim SY, Lee SS, et al. (2016) Sclerosing cholangitis: clinicopathologic features, imaging spectrum, and systemic approach to differential diagnosis. Korean J Radiol 17:25–38CrossRefPubMedPubMedCentral Seo N, Kim SY, Lee SS, et al. (2016) Sclerosing cholangitis: clinicopathologic features, imaging spectrum, and systemic approach to differential diagnosis. Korean J Radiol 17:25–38CrossRefPubMedPubMedCentral
3.
go back to reference Imam MH, Talwalkar JA, Lindor KD (2013) Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management. Clin Liver Dis 17:269–277CrossRefPubMed Imam MH, Talwalkar JA, Lindor KD (2013) Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management. Clin Liver Dis 17:269–277CrossRefPubMed
4.
go back to reference Leonhardt S, Veltzke-Schlieker W, Adler A, et al. (2015) Secondary sclerosing cholangitis in critically ill patients: clinical presentation, cholangiographic features, natural history, and outcome: a series of 16 cases. Medicine 94:e2188CrossRefPubMedPubMedCentral Leonhardt S, Veltzke-Schlieker W, Adler A, et al. (2015) Secondary sclerosing cholangitis in critically ill patients: clinical presentation, cholangiographic features, natural history, and outcome: a series of 16 cases. Medicine 94:e2188CrossRefPubMedPubMedCentral
5.
go back to reference Lin T, Qu K, Xu X, et al. (2014) Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience. Front Med 8:118–126CrossRefPubMed Lin T, Qu K, Xu X, et al. (2014) Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience. Front Med 8:118–126CrossRefPubMed
6.
go back to reference Voigtländer T, Negm A, Schneider A, et al. (2012) Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy 44:1055–1058CrossRefPubMed Voigtländer T, Negm A, Schneider A, et al. (2012) Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy 44:1055–1058CrossRefPubMed
7.
go back to reference Gelbmann CM, Rummele P, Wimmer M, et al. (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221–1229CrossRefPubMed Gelbmann CM, Rummele P, Wimmer M, et al. (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221–1229CrossRefPubMed
8.
go back to reference Ben-Ari Z, Levingston D, Weitzman E, et al. (2015) Secondary sclerosing cholangitis following major burn. Ann Hepatol 14:695–701CrossRef Ben-Ari Z, Levingston D, Weitzman E, et al. (2015) Secondary sclerosing cholangitis following major burn. Ann Hepatol 14:695–701CrossRef
9.
go back to reference Engler S, Elsing C, Flechtenmacher C, et al. (2003) Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52:688–693CrossRefPubMedPubMedCentral Engler S, Elsing C, Flechtenmacher C, et al. (2003) Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52:688–693CrossRefPubMedPubMedCentral
10.
go back to reference Sabashnikov A, Weymann A, Mohite PN, et al. (2014) Risk factors predictive of one-year mortality after lung transplantation. Eur J Cardiothorac Surg 46:e82–e88CrossRefPubMed Sabashnikov A, Weymann A, Mohite PN, et al. (2014) Risk factors predictive of one-year mortality after lung transplantation. Eur J Cardiothorac Surg 46:e82–e88CrossRefPubMed
11.
go back to reference Grimm JC, Valero V 3rd, Magruder JT, et al. (2015) A novel risk score that incorporates recipient and donor variables to predict 1-year mortality in the current era of lung transplantation. J Heart Lung Transplant 34:1449–1454CrossRefPubMed Grimm JC, Valero V 3rd, Magruder JT, et al. (2015) A novel risk score that incorporates recipient and donor variables to predict 1-year mortality in the current era of lung transplantation. J Heart Lung Transplant 34:1449–1454CrossRefPubMed
12.
go back to reference Lee SH, Park MS, Song JH, et al. (2017) Perioperative factors associated with 1-year mortality after lung transplantation: a single-center experience in Korea. J Thoracic Dis 9:4006–4016CrossRef Lee SH, Park MS, Song JH, et al. (2017) Perioperative factors associated with 1-year mortality after lung transplantation: a single-center experience in Korea. J Thoracic Dis 9:4006–4016CrossRef
13.
go back to reference Lee SH, Park MS, Lee JG, et al. (2017) Rare causes of hyperbilirubinemia after lung transplantation: our experience at a single center. J Thoracic Dis 9:5030–5039CrossRef Lee SH, Park MS, Lee JG, et al. (2017) Rare causes of hyperbilirubinemia after lung transplantation: our experience at a single center. J Thoracic Dis 9:5030–5039CrossRef
14.
go back to reference Deltenre P, Valla DC (2008) Ischemic cholangiopathy. Semin Liver Ds 28:235–246CrossRef Deltenre P, Valla DC (2008) Ischemic cholangiopathy. Semin Liver Ds 28:235–246CrossRef
15.
go back to reference Mourad MM, Algarni A, Liossis C, Bramhall SR (2014) Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. WJG 20:6159–6169CrossRefPubMed Mourad MM, Algarni A, Liossis C, Bramhall SR (2014) Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. WJG 20:6159–6169CrossRefPubMed
16.
go back to reference Kochhar G, Parungao JM, Hanouneh IA, Parsi MA (2013) Biliary complications following liver transplantation. WJG 19:2841–2846PubMed Kochhar G, Parungao JM, Hanouneh IA, Parsi MA (2013) Biliary complications following liver transplantation. WJG 19:2841–2846PubMed
17.
go back to reference Novellas S, Caramella T, Fournol M, Gugenheim J, Chevallier P (2008) MR cholangiopancreatography features of the biliary tree after liver transplantation. AJR 191:221–227CrossRefPubMed Novellas S, Caramella T, Fournol M, Gugenheim J, Chevallier P (2008) MR cholangiopancreatography features of the biliary tree after liver transplantation. AJR 191:221–227CrossRefPubMed
Metadata
Title
Radiological patterns of secondary sclerosing cholangitis in patients after lung transplantation
Authors
Hye Jin Kim
Mi-Suk Park
Jin Woo Son
Kyunghwa Han
Jei Hee Lee
Jai Keun Kim
Hyo Chae Paik
Publication date
01-04-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1819-2

Other articles of this Issue 4/2019

Abdominal Radiology 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine